ImmunityBio Stock Soaring Today: Key Catalysts Unpacked
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Index funds often deliver steady returns due to broad diversification and low costs; learn how this supports long-term growth.
25,349 articlesImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Nvidia leads the AI chip race, but AMD has momentum and strategic wins. This guide breaks down who is the better arti...
OKX now lets traders access major US stocks around the clock using cryptocurrency as collateral. The new feature deli...
Linked Polymarket accounts reportedly racked up millions on Iran-related bets, prompting questions about insider info...
A top AI lab warns that its systems could begin self-improvement with minimal human input, triggering renewed calls f...
A veteran market analyst argues that military drones, not consumer EVs, may drive the next leap in battery technology...
Rocket Lab is pursuing a bold $8 billion strategy to merge rocket launches, satellites, and data services. Learn what...
A sweeping wave of public and private spending is reshaping where people live and work. This is the largest infrastru...
A single cloud ETF has become the dominant vehicle for exposure as cloud stocks swing in 2026, prompting a shift away...
When a juggernaut like Fortnite cools its engagement, the ripple effect hits the entire company. This piece digs into...
Investors are debating the right holding period for XRP to maximize returns. New market patterns show patience throug...
A five-month surge has transformed a $10,000 stake in XLK into roughly $13,450, outpacing the S&P 500 and signaling A...